Virtual Screening of Hamigomycin B Natural Product Derivatives in 26 Kinase Proteins by Edmonds, Meagan
• The lowest docking scores were used to determine the best binding and 
orientation of each analog to each protein. Docking data suggests good 
binding of these analogs with five out of twenty-six human kinase proteins. 
Modifications improved targeting for EGFR over other proteins, which was one 
of the five kinases which were determined to have good binding affinity.
• .Of the thirty-three total compounds, hamigeromycin A5, hamigeromycin A2, 
and hamigeromycin B1b were the top binding compounds to the protein EGFR. 
• Evolutionary Trace and Frustration seem to be good guide for the active sites 
of the kinases, as most kinases in the study has a good amount of frustrated 
and evolutionarily important residues in the active site.
• Future in vitro studies are being planned to confirm the computational docking 
results. Preliminary computational results will be disseminated.
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Introduction
Hamigeromycin B and its analogs are synthetic natural
product derivatives that may be useful at mediating signal
transduction activity in human kinases. To study this
potential activity, 11 Hamigomycin analogs were
constructed using MOE 2019 and subjected to energy
minimization using the AMBER14:EHT force field. Each
analog was also compared against the parameters of
Lipinski’s Rules of Five to determine druggability.0 The
compounds were docked into twenty-six human kinase
structures obtained from the Protein Data Bank
(www.rcsb.org) to obtain relative binding free energy
scores using the Docking module of MOE 2019. The binding
sites for these kinase proteins were analyzed using the
Evolutionary Trace server
(http://lichtargelab.org/software/ETserver; Baylor
University; Houston, TX USA) and the Protein
Frustratometer (http://frustratometer.qb.fcen.uba.ar/;
EMBNet Argentina; Buenos Aires, Argentina) to
characterize the energetics and evolutionary information of
the amino acid residues for likely contributions to binding.
Evolutionary Trace performs a multi-sequence alignment
for each kinase in multiple species. It weighs the alignment
against different species based on their relationship in the
phylogenetic tree (e.g., more closely related species are
weighted as more important than more divergent species).
Frustration is based on energy landscape theory; it
compares energy of the native state to a mutated state.
Sites of high frustration can guide binding sites of proteins
and small molecules, as well as sites of evolutionary
importance.
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Conclusion and Future Work
Methods
The 3D X-ray crystal structures of 26 human kinases were
obtained from the protein data bank
(http://www.rcsb.org/) and proteins were modeled using
MOE 2020 (Chemical Computing, Ltd., Montreal, Quebec,
Canada). Each protein and small molecules were modeled
and subjected to energy minimization using the
AMBER14:EHT force field to convergence (0.01 kcal/mol).
The Protein Frustratomer and Evolutionary Trace were used
to identify residues surrounding the active site for docking.
Frustrated residues were determined as those that
displayed a configurational frustration density of 20% or
greater, and mapped onto the 3D ribbon structure of each
protein in green. The top 25% of evolutionarily important
residues were identified as those with the lowest ri
importance scores. These residues were mapped onto the
3D ribbon structure in red. If amino acid residues showed
both energetic frustration and evolutionary importance,
they were mapped onto the 3D ribbon structure in blue.
These maps defined the active site for docking. The
Docking module of MOE 2020 was used for docking
studies. Ten compounds were originally built in MOE for
the docking using the forcefield Amber:14 HBT. These
structures were then docked into the active site of all three
proteins using the Docking module of MOE 2020.
Using the refined protein structures originally from the
PDB, each protein was opened, and any native ligands were
removed from the structure. This also aided in identifying
the active site residues, combined with evolutionary trace
and frustration data. The force field used for docking was
Amber14:EHT implemented in MOE 2020, and the active
site residues were selected as the docking area. Initial
docking obtained 30 docked conformations by placing
triangles in the spaces defined by the van der Waal’s
surface area of the active site cavity London dispersion
forces used to determine initial binding energy. These 30
conformations were further refined using induced fit and
scored with the GBVI/WSA scoring method to calculate the
binding free energy (ΔGbind) in kcal/mol, and five docked
conformations were obtained.
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Figure 1. The figure above shows the 2D structure of the lead,
or prototypical, compound (Hamigeromycin B (1) docked.
Subsequent compounds were modified at various positions on
these rings. The chemical structures of three of the top binding
compounds in EGFR are shown illustrating their modifications.
Figure 2 The kinase displayed above is EGFR (PDB code
5D41) and the top three compounds docked are displayed. A
represents hamigeromycin B (A5) with a binding score of
-8.5605 kcal/mol. B represents hamigeromycin B (A2) with a
binding score of -7.9268 kcal/mol. C represents
hamigeromycin B (1b) with a binding score of -9.6122
kcal/mol. The green color represents amino acid residues
with configurational frustration density of 20% or greater.
Table 1. This table shows the binding free energy values for the
original ten hamigeromycin B analogs versus twenty-six kinases
docked. The lowest (most favorable) binding scores are highlighted in
green; the highest (least favorable) binding scores are highlighted in
red/orange.
Five kinases were found to have good binding affinity and docked in
the second with the modified compounds – JNK, Aurora A, Aurora B,
Hsp90, and EGFR. These five kinases were used for further binding
studies based on modifications of the original lead compounds (see
table 2).
Table 2. This table shows the
binding free energy values of
five kinases identified from the
first round of docking and
docked with twenty-three
modified analogs of
hamigeromycin B. The lowest
(most favorable) binding scores
are highlighted in green; the
highest (least favorable) binding
scores are highlighted in
red/orange.
Table 3. This table shows the druggability of each 
designed analog using Lipinski’s Rules of Five for all thirty-
three compounds. This includes a molecular weight less 
than 500 Da, a Log P of less than 5, five or less H-bond 
donors, and ten or less H-bond acceptors.
Lipinski's Rules MW<500 Da logp H bond donors H bond acceptorshamigeromycin 
B (1) 392.4 1.44 0 8hamigeromycin 
B (A1) 286.33 2.22 0 5hamigeromycin 
B (A2) 420.46 1.45 1 7hamigeromycin 
B (A3) 390.43 1.77 0 6hamigeromycin 
B (A4) 390.4 1.01 0 7hamigeromycin 
B (A5) 376.4 1.55 1 6hamigeromycin 
B (A6) 390.43 1.95 0 6hamigeromycin 
B (A7) 376.4 1.5 1 6hamigeromycin 
B (A8) 362.38 1.09 1 7hamigeromycin 
B (A9) 346.38 1.63 0 6hamigeromycin 
B1a 392.4 1.44 0 8hamigeromycin 
B (1)b 392.4 1.44 0 8hamigeromycin 
B (1)c 392.4 1.44 0 8hamigeromycin 
B (1)d 392.4 1.44 0 8
A1a 286.33 2.22 0 5
A2a 420.46 1.45 1 7
A2b 420.46 1.45 1 7
A3a 390.43 1.77 0 6
A3b 390.43 1.77 0 6
A4a 390.4 1.01 0 7
A4b 390.4 1.01 0 7
A4c 390.4 1.01 0 7
A5b 376.4 1.55 1 6
A6b 390.43 1.95 0 6
A7a 376.4 1.5 1 6
A7b 376.4 1.5 1 6
A7c 376.4 1.5 1 6
A8a 362.38 1.09 1 7
A8b 362.38 1.09 1 7
A8c 362.38 1.09 1 7
A9a 346.38 1.63 0 6
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                ΔGbind (kcal/mol)
Compound NameJNK Aurora-A HSP90 Aurora-B EGFR
B1a -5.7347 -6.5247 -6.6464 -6.7113 -6.6701
B1b -7.4548 -8.3305 -8.8746 -8.305 -9.6122
B1c -7.4506 -7.8399 -8.1839 -7.8431 -9.2961
B1d -7.0002 -7.9601 -8.0897 -7.8496 -8.9867
A1a -7.0258 -7.977 -8.0808 -8.2553 -8.9502
A2a -7.0331 -7.9133 -7.9589 -8.0399 -8.7971
A2b -7.0365 -7.9064 -8.1655 -8.1835 -8.7462
A3a -6.9795 -7.9175 -8.265 -8.1581 -8.7922
A3b -7.0806 -7.6783 -7.9063 -8.0083 -8.7391
A4a -7.3621 -8.0809 -8.6304 -8.3203 -9.0371
A4b -6.5514 -7.9266 -8.3455 -8.2368 -8.6474
A4c -6.6843 -7.9019 -8.4238 -8.2533 -8.5426
A5b -6.9362 -7.9092 -8.4031 -8.2322 -8.577
A6b -6.8592 -7.598 -7.9906 -8.0017 -8.1253
A7a -6.4547 -7.5607 -8.023 -7.9667 -8.113
A7b -6.4309 -7.591 -7.8354 -7.9964 -8.0981
A7c -6.7347 -7.3727 -7.6164 -7.745 -8.0503
A8a -6.6873 -7.352 -7.6809 -7.7322 -8.0897
A8b -6.8361 -7.1207 -7.6515 -7.8417 -8.4814
A8c -7.2647 -7.3115 -7.9418 -8.2441 -8.4553
A9a -7.0956 -7.2901 -7.8337 -7.6027 -8.3389




Compound Name JNK AKT1 Aurora-A Hsp90 Aurora-B VEGF-R2 CDK2 FAK CDK4 B-RAF VE CK2a EphB4 ErbB2 VEGFR3 FLT3 INSR MET PDGF-RB PLK1 SAK TIE COT EGFR SRC
 B1 -6.9925 -5.8224 -7.2479 -7.7678 -8.0329 -7.2129 -7.4102 -7.1565 -5.8045 -7.3026 -7.0541 -7.3359 -6.6728 -5.3727 -6.5045 -6.9088 -7.8676 -5.2119 -7.9917 -5.7351 -5.6981 -6.543 -7.916 -6.843
A1 -9.0911 -5.0363 -6.2614 -6.5444 -7.2169 -6.8597 -6.5537 -6.3263 -5.7545 -6.0148 -6.538 -6.6742 -5.709 -5.3157 -6.7201 -6.3649 -6.4754 -4.2981 -6.6797 -4.72 -5.6377 -6.8071 -6.4416 -6.1478
A2 -7.5339 -5.9617 -8.1148 -8.3042 -8.3585 -8.5305 -7.8517 -7.8035 -6.1349 -7.8098 -6.6747 -8.1125 -6.9889 -5.3511 -7.7131 -7.1007 -7.845 -4.8816 -7.8515 -5.2724 -6.7101 -6.7443 -7.9268 -7.2751
A3 -7.6535 -6.3402 -7.7453 -7.9357 -7.836 -8.1353 -8.0356 -6.997 -5.6108 -7.1495 -7.4815 -7.6497 -6.6497 -5.78 -7.2738 -7.2868 -7.2874 -4.9948 -7.4482 -5.5068 -5.8434 -6.2676 -7.6214 -7.4408
A4 -7.0413 -6.1746 -7.7719 -8.0855 -8.4694 -7.7232 -8.0299 -7.2631 -6.1355 -7.9241 -7.5411 -7.2963 -6.8233 -5.7655 -7.097 -7.1246 -7.5866 -4.9173 -7.5321 -5.5119 -6.0626 -6.7942 -6.1859 -6.9387
A5 -6.7413 -6.6516 -7.5504 -7.6725 -7.8606 -7.3811 -7.6549 -7.1486 -6.1544 -7.8238 -7.0395 -7.2891 -7.06 -5.7679 -7.6999 -7.3127 -7.8555 -5.0883 -7.3516 -5.3296 -6.5106 -8.6352 -8.5605 -6.9674
A6 -7.3557 -6.239 -7.3981 -8.2281 -8.344 -7.8193 -7.8504 -6.4868 -6.1733 -7.1295 -7.4676 -7.1976 -6.801 -5.6342 -7.7557 -7.4986 -7.4473 -5.1161 -7.7984 -5.8371 -6.1173 -6.6462 -7.8812 -7.4965
A7 -6.591 -6.1105 -7.5517 -7.7094 -8.2928 -7.9605 -7.6169 -6.7095 -5.9411 -7.6361 -7.1163 -7.2596 -6.5654 -5.326 -7.4575 -7.3811 -7.5091 -5.3355 -7.5395 -5.5823 -5.8551 -8.5393 -7.1654 -7.094
A8 -6.9427 -6.273 -7.0964 -7.7658 -7.9415 -7.7252 -7.6602 -6.8561 -5.8656 -6.6247 -7.0105 -7.1456 -6.4184 -5.3024 -7.3565 -6.8647 -7.429 -4.689 -6.9755 -5.3761 -5.8168 -6.091 -7.1054 -7.0898
A9 -6.621 -6.1469 -7.256 -7.6003 -7.8216 -7.1523 -7.3756 -6.8453 -5.9272 -6.5886 -7.2008 -7.4937 -6.8272 -5.5899 -7.6721 -6.0724 -7.6042 -4.6425 -7.0224 -5.4606 -6.1391 -6.0912 -6.9313 -6.8231
